NCT07780487Completed
Phipps Conservatory's 5210 Let's Move Pittsburgh and Impact on Youth With T1D
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
Managing T1D requires a demanding regimen to keep blood sugars in control and stay healthy. Despite recent advances, this remains extremely challenging for children and their families, who usually report having the most difficulty with the healthy eating aspect of the management, sometimes more so than having to administer insulin or monitor sugar levels. In addition to high sugars, the rise in obesity in the last decades has contributed to the risk of long-term complications of T1D such as cardiovascular disease and renal failure. More than a third of youngsters with T1D are now overweight which makes the management of T1D much more challenging. The problem of obesity is much greater in the socially and economically disadvantaged groups as healthy eating is considered expensive. To educate kids with T1D and their families on healthy eating on a reasonable budget, in partnership with Phipps Conservatory's 5210 Let's Move Pittsburgh program, the investigators initiated virtual cooking classes during the early days of the COVID-19 pandemic. This proposal's objective is to start to evaluate the potential medical benefits as the investigators expand this program. The investigators expect the children who participate will show improvement in diabetes control, favorable decrease or maintenance of their weight and BMI when compared to their pre-intervention visit and to the control group, and improved knowledge about nutrition and healthy food choices when comparing pre- and post-intervention assessments.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 7 Aug 2026
- Start date
- 4 Dec 2023
- Primary completion date
- 19 Mar 2025
- Lead sponsor
- University of Pittsburgh
- Diseases
- Type 1 diabetes
- NCT number
- NCT07780487
What you commit to
- Study type: Interventional
- Participants enrolled: 46
- From 4 Dec 2023 to the primary completion date, 19 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- diagnosis of other types of diabetes (such as type 2 diabetes, MODY, cystic fibrosis related diabetes or diabetes secondary to medications).
Who the study is looking for
- be diagnosed with T1D for at least a year
- be 12 to 17 years of age at time of study enrollment
- have a BMI ≥ 85th percentile
- be able to communicate via a virtual platform if needed
- intend to maintain status as a patient at the Children's Hospital of Pittsburgh Diabetes Center throughout the study duration.
Age in the registry: 12 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UPMC Children's Hospital of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.